Detalles de la búsqueda
1.
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients.
Ann Hematol
; 101(9): 2053-2067, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35780254
2.
SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group.
Am J Hematol
; 97(1): 30-42, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34695229
3.
Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis.
Ann Hematol
; 94(6): 947-54, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25672649
4.
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant.
Cancers (Basel)
; 16(2)2024 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38254867
5.
Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study.
BMJ Open
; 13(7): e071371, 2023 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37491085
6.
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients.
Blood Cancer J
; 13(1): 8, 2023 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36599843
7.
SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination.
Bone Marrow Transplant
; 58(5): 567-580, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36854892
8.
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients.
Viruses
; 15(10)2023 10 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37896843
9.
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE).
Bone Marrow Transplant
; 58(6): 659-666, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36894635
10.
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study.
Cancers (Basel)
; 15(5)2023 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900296
11.
SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders.
J Hematol Oncol
; 15(1): 54, 2022 05 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35526045
12.
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients.
Leuk Lymphoma
; 63(3): 538-550, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34668835
13.
COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey.
Leukemia
; 35(10): 2885-2894, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34079042
14.
Risk factors and outcome of COVID-19 in patients with hematological malignancies.
Exp Hematol Oncol
; 9: 21, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32864192
15.
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.
J Hematol Oncol
; 13(1): 133, 2020 10 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33032660
16.
Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19.
Blood Adv
; 6(3): 848-853, 2022 01 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34905620
Resultados
1 -
16
de 16
1
Próxima >
>>